| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/08/2013 | US20130203828 Pharmaceutical compositions comprising poh derivatives |
| 08/08/2013 | US20130203808 Drug for degradation and treatment of biofilms |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130203799 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 08/08/2013 | US20130203793 Protection and Treatment Against Influenza Infection |
| 08/08/2013 | US20130203786 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
| 08/08/2013 | US20130203769 Targeting Metabolic Adaptive Responses to Chemotherapy |
| 08/08/2013 | US20130203768 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases |
| 08/08/2013 | US20130203766 Pharmaceutical Compositions for the Treatment of Sexual Disorders II |
| 08/08/2013 | US20130203759 ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT |
| 08/08/2013 | US20130203757 Compounds And Compositions For Treating Cancer |
| 08/08/2013 | US20130203755 Bicyclic heteroaryl kinase inhibitors and methods of use |
| 08/08/2013 | US20130203751 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof |
| 08/08/2013 | US20130203739 Cyclic amide derivative |
| 08/08/2013 | US20130203730 Benzothiazoles as ghrelin receptor modulators |
| 08/08/2013 | US20130203725 Method to treat small cell lung cancer |
| 08/08/2013 | US20130203715 Use of trp channel agonists to treat infections |
| 08/08/2013 | US20130203705 Pyrazole Compounds Acting Against Allergic, Immune and Inflammatory Conditions |
| 08/08/2013 | US20130203698 Aqueous iron carbohydrate complexes, their production and medicaments containing them |
| 08/08/2013 | US20130203695 Hypersulfated disaccharides to treat elastase related disorders |
| 08/08/2013 | US20130203692 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
| 08/08/2013 | US20130203681 Macrocyclic Compounds Useful as Inhibitors of Histone Deacetylases |
| 08/08/2013 | US20130203678 Compstatin analogs for treatment of neuropathic pain |
| 08/08/2013 | US20130203671 Flibanserin for the Treatment of Urinary Incontinence and Related Diseases |
| 08/08/2013 | US20130203670 Therapy For Vitiligo |
| 08/08/2013 | US20130203653 Bacterial-derived blis for treatment of acne |
| 08/08/2013 | US20130203646 Supporting activities of daily living |
| 08/08/2013 | US20130203169 Conditioned cell culture medium compositions and methods of use |
| 08/08/2013 | US20130202720 Methods of treating hepatitis |
| 08/08/2013 | US20130202707 Controlled Delivery of TLR Agonists in Structural Polymeric Devices |
| 08/08/2013 | US20130202693 Oral Dosage Forms of Bendamustine |
| 08/08/2013 | US20130202685 Use of a histamine H4 antagonist for the treatment of post-operative adhesions |
| 08/08/2013 | US20130202682 Synthetic matrix vesicles for biomimetic mineralization |
| 08/08/2013 | US20130202673 Heterogeneous implantable devices for drug delivery |
| 08/08/2013 | US20130202663 Remedy |
| 08/08/2013 | US20130202655 Vaccines, Methods of Administering Vaccines, Methods and Products for Treating and/or Delaying Onset of Dysplastic Lesions, and Wafers for Oral Administration |
| 08/08/2013 | US20130202654 Topical Foam Composition |
| 08/08/2013 | US20130202639 Synthetic Herpes Simplex Viruses for Treatment of Cancers |
| 08/08/2013 | US20130202637 Dietary Supplements Including Ellagitannins and Ellagic Acid |
| 08/08/2013 | US20130202623 Pd-1 modulation and uses thereof for modulating hiv replication |
| 08/08/2013 | US20130202618 Antibodies for the treatment of clostridium difficile-associated infection and disease |
| 08/08/2013 | US20130202615 Anti-vegf antibodies and uses thereof |
| 08/08/2013 | US20130202613 Pharmacological vitreolysis |
| 08/08/2013 | US20130202611 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 08/08/2013 | US20130202590 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
| 08/08/2013 | US20130202580 Use Of 2,5-Dihydroxybenzene Derivatives For Treating Actinic Keratosis |
| 08/08/2013 | US20130202573 Thioacetate compounds, compositions and methods of use |
| 08/08/2013 | US20130202556 Treatment of Hepatitis C Virus Related Diseases Using Hydroxychloroquine or a Combination of Hydroxychloroquine and an Anti-Viral Agent |
| 08/08/2013 | US20130202555 Treatment of multiple sclerosis with masitinib |
| 08/08/2013 | US20130202528 Differential gene expression in physiological and pathological angiogenesis |
| 08/08/2013 | CA2861377A1 Combination of a rtk inhibitor with an anti - estrogen and use thereof for the treatment of cancer |
| 08/07/2013 | EP2623119A1 Glioma treatment method, glioma examination method, method of delivering a desired material to a glioma, and drug used in said methods |
| 08/07/2013 | EP2621949A1 Polypeptides that bind to human complement component c5 |
| 08/07/2013 | EP2621588A2 Methods and compositions for disease treatment using inhalation |
| 08/07/2013 | EP2621530A2 Improved adjuvant system for vaccine administration |
| 08/07/2013 | EP2621501A1 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases |
| 08/07/2013 | EP2621498A2 Combination treatment for dermatological conditions |
| 08/07/2013 | EP2621495A1 Combination therapy for treating hcv infection |
| 08/07/2013 | EP2621483A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 08/07/2013 | EP2621282A2 Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes |
| 08/07/2013 | CN1515244B Protein-stable pharmacological active matter, its preparation and application method |
| 08/07/2013 | CN103232539A Antibodies to opgl |
| 08/07/2013 | CN103232381A Peptidomimetic protease inhibitors |
| 08/07/2013 | CN103230594A Medicine composition of alpha-glucosidase inhibitor and vitamin B |
| 08/07/2013 | CN103230593A Medicine composition used for treating gastrointestinal diseases |
| 08/07/2013 | CN103230592A Composition of statin medicine and 5-methyltetrahydrofolic acid, and application thereof |
| 08/07/2013 | CN103230385A Preparation method of transdermal drug delivery system (TDDS) |
| 08/07/2013 | CN103230377A Antibiosis fishing medicament processing method |
| 08/07/2013 | CN103230361A Antacid preparation with novel release behavior |
| 08/07/2013 | CN102675655B Water-soluble fullerene and preparation and application methods thereof |
| 08/07/2013 | CN101663039B Use of chitosans to increase nail growth rate |
| 08/06/2013 | US8504303 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 08/06/2013 | US8501906 Compounds and methods for treating cancer |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | US8501199 Synthetic blocking reagents |
| 08/06/2013 | CA2714081C Methods and compositions for treating conditions of the eye |
| 08/06/2013 | CA2630624C Compositions and methods for increasing insulin sensitivity |
| 08/06/2013 | CA2519429C Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
| 08/06/2013 | CA2477075C Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 08/06/2013 | CA2425779C Compositions that inhibit proliferation of cancer cells |
| 08/06/2013 | CA2388807C Viruses for the treatment of cellular proliferative disorders |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/01/2013 | WO2013111897A1 Novel antitumor agent and method for screening same |
| 08/01/2013 | WO2013111770A1 Novel anti-malignant tumor agent |
| 08/01/2013 | WO2013111714A1 Prophylactic or therapeutic agent for bronchial asthma and method for screening same |
| 08/01/2013 | WO2013110756A1 Ingenol mebutate in combination with cryotherapy for the treatment of actinic keratosis |
| 08/01/2013 | WO2013110749A1 Therapeutic use of activators of zinc finger protein gli3 |
| 08/01/2013 | WO2013110354A1 Compositions and methods for cell transplantation |
| 08/01/2013 | WO2013110280A1 Panobinostat for use in the treatment of hiv-1 |
| 08/01/2013 | WO2013083826A3 Glp-1 agonists |
| 08/01/2013 | WO2013083813A3 Modulators of spermine/spermidine n'-acetyltransferase (ssat) and ssat associated proteins for use in prevention or treatment of rheumatoid arthritis |
| 08/01/2013 | WO2013041967A3 Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism |
| 08/01/2013 | US20130197210 Complexing agents for compositions containing inclusion complexes |
| 08/01/2013 | US20130197103 Composition and method for the enhancement of the efficacy of drugs |
| 08/01/2013 | US20130197095 Substituted 4-aminocyclohexane derivatives |
| 08/01/2013 | US20130197090 Postural stability and incident functions in patients |
| 08/01/2013 | US20130197086 Procedure for the obtainment of fatty acids of pharmacological and nutritional interest |
| 08/01/2013 | US20130197034 Salts Of Methyl 2-((R)-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3-((R)-Tetrahydro-2H-Pyran-3-Yl)Propylcarbamoyl)Piperidin-3-Yl)Methoxy)Ethylcarbamate |
| 08/01/2013 | US20130197019 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |